ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666850; 2) Community: the network communities that were significantly associated with the response to NSC 666850; 3) Molecule: the relationships between components within communities and NSC 666850; 4) MDR: the compounds that were significantly associated with the NSC 666850.

NSC Compound Enrichment Correlation
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.000572036815736153 0.37947897
NSC 208734 ACLACINOMYCIN A 0.000601164336889762 0.38376765
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.000601164336889762 0.54569017
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.000601164336889762 0.1840905
NSC 683555 Camptothecin Derivative 0.000601164336889762 0.021232928
NSC 712735 Null 0.000601164336889762 0.47284257
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.000614175706312797 0.11523916
NSC 733882 6-(3-Azidopropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.000614175706312797 0.095218724
NSC 606497 Camptothecin Derivative 0.00103112124545269 0.0021800718
NSC 63878 Cytarabine Hydrochloride AZ 0.00103112124545269 0.11442986
Total:103  Current:4    [First] [Prev] [Next] [Last]